X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

IP Explained: How Hatch-Waxman successfully balances affordability and innovation

By Tom Wilbur  |    May 22, 2019
For three decades, The Drug Price Competition and Patent Term Restoration Act, more commonly known as the Hatch-Waxman Act, has fostered innovation, spurred competition and helped the United...   Read More

IP Explained: Myth vs. fact about strong patent protections in the biopharmaceutical industry

By Tom Wilbur  |    May 2, 2019
Strong patent protections are fundamental to the creation of new treatments and cures that extend and improve patients’ lives. In recent years, critics of the biopharmaceutical industry have...   Read More

IP Explained: What they are saying on the importance of strong intellectual property protections

By Tom Wilbur  |    April 24, 2019
The U.S. biopharmaceutical industry depends on predictable and reliable intellectual property (IP) protections to maintain its role as the global leader in biopharmaceutical innovation. Strong and...   Read More

IP Explained: Why patents are so critical to biopharmaceutical innovation

By Tom Wilbur  |    April 16, 2019
Today, we are excited to launch our new IP Explained Catalyst series, where each week we’ll break down critical components of the intellectual property (IP) system and the important role it plays...   Read More

New report: Using march-in authority would jeopardize U.S. innovation

By Tom Wilbur  |    March 19, 2019
In 1980, Congress passed the Small Business Patent Procedures Act, better known as the Bayh-Dole Act, which created a uniform framework for transferring government-funded research into useful...   Read More

Special 301 submission calls for a level playing field for American innovators

By Megan Van Etten  |    March 13, 2019
The Office of the U.S. Trade Representative (USTR)’s 2019 Special 301 Report – scheduled to be released this spring – brings critical attention to overseas intellectual property (IP) and market...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates